You are here

Teijin Pharma

Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront

Fierce Biotech

Thu, 11/30/23 - 10:19 am

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

Fierce Pharma

Wed, 03/3/21 - 12:01 am

A Feeding Frenzy over ROR Gamma T Modulators

invivoblog

Sat, 08/3/13 - 10:58 am

Bonalon Jelly 35 mg Approved as World’s First Oral Jelly for Osteoporosis

PharmaLive

Thu, 08/16/12 - 01:46 pm